COMBANTRIN

This brand name is authorized in Austria, Canada, France, Japan, Mexico, New Zealand, South Africa.

Active ingredients

The drug COMBANTRIN contains one active pharmaceutical ingredient (API):

1	Pyrantel UNII 81BK194Z5M - PYRANTEL PAMOATE
	Pyrantel acts as a cholinergic agonist. Its mode of action is to stimulate nicotinic cholinergic receptors of the parasite, induce spastic paralysis of the nematodes and thereby allow removal from the gastro intestinal (GI) system by peristalsis.
	Read more about Pyrantel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CC01	Pyrantel	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CC Tetrahydropyrimidine derivatives
Discover more medicines within P02CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	01944363
FR	Base de données publique des médicaments	61429046, 69990800
JP	医薬品医療機器総合機構	6429001F1036, 6429001R1032
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	76803, 76888
NZ	Medicines and Medical Devices Safety Authority	1545
ZA	Health Products Regulatory Authority	D/12/260, J/12/200